Details of the Drug Reposition

General Information of This Drug (ID: DMXMHBB)

Drug Name
Ammonium lactate   DMXMHBB
Synonyms Ammonium lactate); BMS-186091; Lac-Hydrin; Ammonium lactate, Bristol-Myers Squibb
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Granuloma annulare DISMOUMI N.A. Approved [1]
Exanthem DISAFOQN N.A. Approved [1]
Skin disease DISDW8R6 EA00-EM0Z Approved [1]
------------------------------------------------------------------------------------
3 Discontinued in Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Atopic dermatitis DISTCP41 EA80 Discontinued in Phase 2 [2]
Seborrhoeic dermatitis DISNWVJU EA81 Discontinued in Phase 2 [3]
Contact dermatitis DISQ3AU0 EK0Z Discontinued in Phase 2 [4]
------------------------------------------------------------------------------------
1 Investigative Indication(s)
Indication Name Indication ID ICD-11 Status REF
Pruritus DISVH62W EC90 Investigative [1]
------------------------------------------------------------------------------------

References

1 Ammonium lactate FDA Label
2 A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors
3 Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer
4 Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer